<?xml version="1.0"?>
<rss version="2.0">
<channel>
<title><![CDATA[Evan Rappaport]]></title>
<link>/profile/evan-rappaport/erappaport357/rss20/</link>
<description><![CDATA[A private citizen working for the public good.]]></description>
<item>
<title><![CDATA[Why the Lilly Delay, FDA?]]></title>
<link>http://www.fool.com/investing/high-growth/2008/06/25/why-the-lilly-delay-fda.aspx</link>
<guid isPermaLink="false">http://www.fool.com/investing/high-growth/2008/06/25/why-the-lilly-delay-fda.aspx</guid>
<pubDate>Mon, 07 Jul 2008 17:48:52 EDT</pubDate>
<description><![CDATA[It looks like investors will have to wait a little longer to get news about Eli Lilly's (NYSE: LLY) potentially game-changing pipeline compound prasugrel. On Monday, the FDA pushed back its target review date for Lilly's marketing application of the heart drug by three months, to Sept. 26.]]></description>
</item>
<item>
<title><![CDATA[US FDA urging black box warning for epilepsy drugs]]></title>
<link>http://www.reuters.com/article/marketsNews/idINN0742930620080707?rpc=44</link>
<guid isPermaLink="false">http://www.reuters.com/article/marketsNews/idINN0742930620080707?rpc=44</guid>
<pubDate>Mon, 07 Jul 2008 17:47:14 EDT</pubDate>
<description><![CDATA[Food and Drug Administration officials are pushing for a &quot;black box&quot; warning about the risk of suicidal thoughts and behavior with epilepsy drugs, just days ahead of a public meeting on the issue.]]></description>
</item>
<item>
<title><![CDATA[US advisers urge higher bar for new diabetes drugs]]></title>
<link>http://www.reuters.com/article/marketsNews/idINN0241429420080702?rpc=44</link>
<guid isPermaLink="false">http://www.reuters.com/article/marketsNews/idINN0241429420080702?rpc=44</guid>
<pubDate>Mon, 07 Jul 2008 17:46:18 EDT</pubDate>
<description><![CDATA[U.S. regulators should require drugmakers to study the potential heart risks of all new diabetes medicines, an advisory panel said on Wednesday.]]></description>
</item>
</channel>
</rss>